LiRIS Biomedical
Latest round
- Series B
Last raised
- Dec 2017
Total raised
- $103M
Investors
- 8
About LiRIS Biomedical
LiRIS Biomedical, Inc. is a biotechnology firm focused on developing innovative treatments for patients with cancer and other serious diseases.LiRIS Biomedical, Inc. specializes in the development of targeted therapeutic solutions for oncology. Founded in 2008 in Lexington, US, the company has successfully completed a total of 9 deals, with its most recent deal occurring on December 20, 2019. On this date, LiRIS Biomedical was acquired by Johnson & Johnson, although financial terms were not disclosed. The company was founded by a team of professionals with expertise in biomedical engineering and drug development, although individual founder names are not mentioned.LiRIS Biomedical, Inc. provides advanced biotechnological solutions primarily in the field of cancer treatment. The company's product offerings are centered around targeted therapies aimed at addressing specific cancer types, enhancing treatment precision and efficiency.LiRIS Biomedical, Inc. generates revenue through the commercialization of its innovative therapeutic products. The revenue model is based on B2B transactions with healthcare institutions and potential partnerships with pharmaceutical distributors and healthcare providers.LiRIS Biomedical, Inc. The company is also looking to expand its market reach into Europe and Asia by 2022, aiming to establish partnerships with healthcare providers in these regions. Following the acquisition by Johnson & Johnson, the company will leverage additional resources to enhance its research capabilities and foster innovation in cancer treatments.
Who invested in LiRIS Biomedical
8 investors across 5 rounds
See all investors in LiRIS Biomedical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about LiRIS Biomedical
Who invested in LiRIS Biomedical?
LiRIS Biomedical has 8 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LiRIS Biomedical raised?
LiRIS Biomedical has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did LiRIS Biomedical last raise money?
LiRIS Biomedical's most recent round on record is a Series B, in Dec 2017.
What does LiRIS Biomedical do?
LiRIS Biomedical is a pharmaceuticals company.
Where is LiRIS Biomedical headquartered?
LiRIS Biomedical is headquartered in Lexington, US.
Which VCs invest in companies like LiRIS Biomedical?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at LiRIS Biomedical's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like LiRIS Biomedical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.